Sharemarkets on steroids – but not the NZX

Sharemarkets on steroids – but not the NZX
2021 has shown strong performances of global sharemarkets with the exception of the NZX benchmark index. (Image: Deposit Photos)
Brian Gaynor
The first six months of the year has been a great period for global sharemarkets, with the notable exception of the NZX benchmark index.Wall Street has been particularly strong, with the heavily technology weighted Nasdaq up 12.5% since the end of 2020 while the broader based S&P 500 Index appreciated 14.4%. Meanwhile, the ASX benchmark index gained 11% for the six months to June 30 while the NZX50 Capital Index was down 4.5%. The NZX50 Gross Index was off 3.3% for the six months but the capital index has been used in this column for c...

More Opinion

Benchmark-beaters: how ESG gives indexers active power
Opinion

David Chaplin: Benchmark-beaters: how ESG gives indexers active power

The ESG push among institutional investors is changing the mix.

Has ArborGen finally crossed the Rubicon?
Opinion

Paul McBeth: Has ArborGen finally crossed the Rubicon?

Long-suffering shareholders might be dubious about the emerging green shoots.

Paul McBeth 02 Jul 2024
Our nation of tinkerers
Opinion

Simon Robertson: Our nation of tinkerers

From wine to Wētā, New Zealanders are always excelling at something.  

Simon Robertson 29 Jun 2024
How to protect your business's brand
Opinion

Georgina Toomey: How to protect your business's brand

Monitor anyone using your trademarks to protect it. 

Georgina Toomey 27 Jun 2024